Literature DB >> 31087157

Prognostic relevance of new onset arrhythmia and ICD shocks in primary prophylactic ICD patients.

Thomas Kleemann1, Margit Strauss2, Kleopatra Kouraki2, Nicolas Werner2, Ralf Zahn2.   

Abstract

BACKGROUND: The prognostic relevance of new onset arrhythmias compared to ICD shocks in ICD patients is not well known.
OBJECTIVES: Aim of the study was to evaluate the prognostic relevance of new onset atrial fibrillation (AF) or ventricular arrhythmias (VT/VF) compared to ICD shocks in primary prophylactic ICD-patients.
METHODS: A total of 622 of 1955 (32%) patients of the prospective single-centre ICD-registry Ludwigshafen with primary prophylactic ICD indication and sinus rhythm (SR) at baseline without history of AF were analyzed. All patients underwent an ICD implantation between 1992 and 2012.
RESULTS: During the median follow-up time of 6 years, 200 (32%) ICD patients developed new AF and 249 (40%) patients new VT/VF. There was an approximately 10% increase of 5-year mortality rate depending on the type of new onset arrhythmia (no arrhythmia 19%, new AF 28%, new VT 36% and new VF 55% 5-year mortality). In a multivariate analysis, new onset of AF or VT/VF was an independent predictor for increased mortality whereas VT shocks and inappropriate ICD shocks were not.
CONCLUSION: More than half of primary prophylactic ICD patients with SR at baseline develop new AF or VT/VF after 6 years. New onset arrhythmias of AF and VT/VF are independent prognostic factors for increased mortality in primary prophylactic ICD patients. ICD shocks itself, inappropriate or appropriate, are not additionally associated with a worse outcome. These results support the hypothesis that in clinical practice rather the arrhythmia than the ICD shock itself is responsible for a deteriorated prognosis.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; Defibrillation; ICD shock; Implantable cardioverter defibrillator (ICD); Prognosis; Ventricular arrhythmia

Year:  2019        PMID: 31087157     DOI: 10.1007/s00392-019-01491-1

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  19 in total

1.  Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.

Authors:  Thomas Kleemann; Matthias Hochadel; Margit Strauss; Alexandros Skarlos; Karlheinz Seidl; Ralf Zahn
Journal:  J Cardiovasc Electrophysiol       Date:  2012-02-07

2.  Prognostic Significance of Nonsustained Ventricular Tachycardia Episodes Occurring Early After Implantable Cardioverter-Defibrillator Implantation Among Patients With Left Ventricular Dysfunction.

Authors:  Javier Jiménez-Candil; Jesús Hernández; Pedro Perdiguero; Ana Martín; José Moríñigo; Loreto Bravo; Olga Durán; Pedro Luis Sánchez
Journal:  Am J Cardiol       Date:  2016-08-23       Impact factor: 2.778

Review 3.  Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.

Authors:  Vern Hsen Tan; Stephen B Wilton; Vikas Kuriachan; Glen L Sumner; Derek V Exner
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-01-20

4.  Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.

Authors:  Thomas Kleemann; Margit Strauss; Kleopatra Kouraki; Ralf Zahn
Journal:  Europace       Date:  2015-02-16       Impact factor: 5.214

5.  Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).

Authors:  Anne-Christine Ruwald; Claudio Schuger; Arthur J Moss; Valentina Kutyifa; Brian Olshansky; Henry Greenberg; David S Cannom; N A Mark Estes; Martin H Ruwald; David T Huang; Helmut Klein; Scott McNitt; Christopher A Beck; Robert Goldstein; Mary W Brown; Josef Kautzner; Morio Shoda; David Wilber; Wojciech Zareba; James P Daubert
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08-18

6.  A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.

Authors:  Bruce L Wilkoff; Kevin T Ousdigian; Laurence D Sterns; Zengri J Wang; Ryan D Wilson; John M Morgan
Journal:  J Am Coll Cardiol       Date:  2006-06-22       Impact factor: 24.094

7.  Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.

Authors:  T Jared Bunch; John D Day; Brian Olshansky; Kira Q Stolen; Christopher M Mullin
Journal:  Heart Rhythm       Date:  2008-09-27       Impact factor: 6.343

8.  Catheter Ablation for Atrial Fibrillation with Heart Failure.

Authors:  Nassir F Marrouche; Johannes Brachmann; Dietrich Andresen; Jürgen Siebels; Lucas Boersma; Luc Jordaens; Béla Merkely; Evgeny Pokushalov; Prashanthan Sanders; Jochen Proff; Heribert Schunkert; Hildegard Christ; Jürgen Vogt; Dietmar Bänsch
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

Review 9.  Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis.

Authors:  Paul A Scott; John Silberbauer; Theresa A McDonagh; Francis D Murgatroyd
Journal:  Heart Rhythm       Date:  2014-02-12       Impact factor: 6.343

10.  Reduction in inappropriate therapy and mortality through ICD programming.

Authors:  Arthur J Moss; Claudio Schuger; Christopher A Beck; Mary W Brown; David S Cannom; James P Daubert; N A Mark Estes; Henry Greenberg; W Jackson Hall; David T Huang; Josef Kautzner; Helmut Klein; Scott McNitt; Brian Olshansky; Morio Shoda; David Wilber; Wojciech Zareba
Journal:  N Engl J Med       Date:  2012-11-06       Impact factor: 91.245

View more
  2 in total

1.  Outcomes in patients with dual antegrade conduction in the atrioventricular node: insights from a multicentre observational study.

Authors:  Jens Hartmann; Christiane Jungen; Sebastian Stec; Niklas Klatt; Stephan Willems; Hisaki Makimoto; Daniel Steven; Helmut Pürerfellner; Martin Martinek; Christian Meyer
Journal:  Clin Res Cardiol       Date:  2020-01-30       Impact factor: 5.460

Review 2.  Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?

Authors:  Ahsan A Khan; Giuseppe Boriani; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2019-09-14       Impact factor: 5.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.